Beacon Bridge Wealth Partners, LLC Abb Vie Inc. Transaction History
Beacon Bridge Wealth Partners, LLC
- $218 Billion
- Q2 2024
A detailed history of Beacon Bridge Wealth Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beacon Bridge Wealth Partners, LLC holds 1,609 shares of ABBV stock, worth $324,213. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,609
Previous 1,959
17.87%
Holding current value
$324,213
Previous $357 Million
22.64%
% of portfolio
0.13%
Previous 0.17%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,760Shares Held
1.28BCall Options Held
13MPut Options Held
9.83M-
Vanguard Group Inc Valley Forge, PA171MShares$34.4 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.7 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.8 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.78 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $356B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...